Antitumor effect of allogeneic hematopoietic SCT in metastatic medulloblastoma

Bone Marrow Transplantation

Volumn 42, Issue 2, 2008, Pages 131-133

  Secondino, S ^a   Pedrazzoli, P ^a   Schiavetto, I ^a   Basilico, V ^a   Bramerio, E ^a   Massimino, M ^b   Gambacorta, M ^a   Siena, S ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTINUCLEAR ANTIBODY; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; ITRACONAZOLE; LEVOFLOXACIN; METHOTREXATE; PREDNISONE; STEROID; THIOTEPA;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; ANTINEOPLASTIC ACTIVITY; BACTERIAL INFECTION; BONE MARROW BIOPSY; CASE REPORT; DERMATOMYOSITIS; DRUG DOSE REDUCTION; ENGRAFTMENT; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; LIVER BIOPSY; LOW DRUG DOSE; MEDULLOBLASTOMA; METASTASIS; MUSCLE WEAKNESS; MYCOSIS; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PUVA; THROMBOCYTOPENIA; VIRUS INFECTION;

ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MEDULLOBLASTOMA; NEOPLASM METASTASIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 48349107198     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.86     Document Type: Letter

References (10)

1. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S et al. Regression of metastatic renal-cell carcinoma after non-myeloablative allogenic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750-758.
2. Renga M, Pedrazzoli P, Siena S. Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumors. Ann Oncol 2003; 14: 1177-1184.
3. Matsuda Y, Hara J, Osugi Y, Fujisaki H, Takai K, Ohta H et al. Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors. Bone Marrow Transplant 1998; 21: 355-360.
4. Lundberg JH, Weissman DE, Beatty PA, Ash RC. Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation. J Neurooncol 1992; 13: 151-155.
5. Spreafico F, Massimino M, Gandola L, Cefalo G, Mazza E, Landonio G et al. Survival of adults treated for medulloblastoma using paediatric protocols. Eur J Cancer 2005; 41: 1304-1310.
6. Pedrazzoli P, Da Prada GA, Giorgiani G, Schiavo R, Zambelli A, Giraldi E et al. Allogeneic stem cell transplantation after a reduced-intensity, preparative regimen. A pilot study in patients with refractory malignancies. Cancer 2002; 94: 2409-2415.
7. + cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360-1377.
8. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994; 14 845-848.
9. Kunschner LJ, Kuttesch J, Hess K, Yung WK. Survival and recurrence factors in adult medulloblastoma: The MD Anderson Cancer Center experience from 1978 to 1998. Neurooncol 2001; 3: 167-173.
10. Bacigalupo A. Management of acute graft-versus-host disease. Br J Haematol 2007; 137: 87-98.